Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Source:

Nursing2015

October 2004, Volume 34 Number 10 , p 73 - 73

Author

  • LYNN C. HADAWAY RN,C, CRNI, MED

Abstract

Outline

  • SELECTED REFERENCES

    RALPH ADAMS, 69, who has a history of lung cancer, was just admitted to your unit with possible pneumonia. He has an implanted port on the right side of his upper chest. In his chart, you see an order for 1 mg of warfarin daily—an extremely small dose. Mr. Adams doesn't have atrial fibrillation or a history of thromboembolism. So why is he receiving this drug?

    The small dose of warfarin is indicated to guard against catheter-related thrombosis, a common cause of catheter malfunction. Cancer leads to a hypercoagulable state, especially in patients with solid tumors. The presence of any central venous catheter adds to the risk of thrombus formation.

    Catheter-related thrombosis limits the life of a central venous catheter, decreases the catheter's usefulness, and interrupts infusion therapy. Catheter-related thrombi can also spawn dangerous pulmonary emboli. Despite many unanswered questions, a growing body ...

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: